Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-021991

EVP & Chief R & QA Officer sold 100,203 shares at an average $37.87 ($3,795,062)

  • EVP & Chief R & QA Officer acquired 72,754 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Clark Mitchall G. · EVP & Chief R & QA Officer

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-27 Exercise or conversion : show line 1 in the form +28,848 $25.15 $725,527 212,368 D
2018-03-27 Exercise or conversion : show line 2 in the form +32,500 $22.72 $738,400 244,868 D
2018-03-27 Exercise or conversion : show line 3 in the form +11,406 $11.00 $125,466 256,274 D
2018-03-27 Sale : show line 4 in the form −22,794 $36.43 $830,385 233,480 D
2018-03-27 Sale : show line 5 in the form −31,356 $37.10 $1,163,308 202,124 D
2018-03-27 Sale : show line 6 in the form −29,980 $38.23 $1,146,135 172,144 D
2018-03-27 Sale : show line 7 in the form −2,170 $39.53 $85,780 169,974 D
2018-03-27 Sale : show line 8 in the form −2,800 $40.40 $113,120 167,174 D
2018-03-27 Sale : show line 9 in the form −11,103 $41.10 $456,333 156,071 D
Open-market sales · 100,203 sh · avg $37.87 · $3,795,062

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2018-03-27 Exercise or conversion : show line 10 in the form Employee Stock Option (Right to Buy) −28,848 11,194 D
2018-03-27 Exercise or conversion : show line 11 in the form Employee Stock Option (Right to Buy) −32,500 32,500 D
2018-03-27 Exercise or conversion : show line 12 in the form Employee Stock Option (Right to Buy) −11,406 3,125 D
Loading xslF345X03/doc4.xml…